N-0923 dopamine agonist transdermal patch data

The company announced preliminary data from an interim analysis of its Phase IIb trial of

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE